Skip to main content
KBS_Icon_questionmark link-ico


Cancer Prevention Group


Cancer Prevention Group

We are a group of epidemiologist, behavioural scientists and statisticians studying the causes of or early events in the development of cancer.

We are comprised of three groups:




We evaluate current approaches to screening and study new screening technologies.

We study how to optimise the efficacy and cost-effectiveness and minimise the harms of screening programmes by generating evidence on:

  • Screening intervals
  • Benefits and harms of screening at different ages
  • Reasons for differences in screening performance
  • Researching risk-based screening and the potential for personalised screening regimens
  • Studying technologies that could improve existing screening programmes; or help develop screening at new sites. For example:

- We are studying vaginal self-sampling which may improve cervical screening coverage.

- We are working with Professor Fitzgerald’s group in Cambridge on the BEST3 study. This investigates the potential of a Cytosponge to screen for Barrett’s oesophagus and reduce mortality from adenocarcinoma of the oesophagus.

- We will assess polygenic risk with the goal of developing risk-based personalised screening intervals for breast and prostate cancer.




Our core funding is provided by Cancer Research UK.

Cancer Research UK logo